Neutralizing activity against authentic SARS-CoV-2 virus and sequence analysis of neutralizing antibodies
(A and B) Neutralizing activity of selected antibodies against authentic SARS-CoV-2 virus.
(C and D) IGHV gene usage of neutralizing antibodies.
(E) Phylogenetic tree of neutralizing antibodies.
(F–H) CDR3H length distribution (F), number of amino acid mutations (G), and amino acid mutation rate (H) of IGHV.
The neutralization values are the mean of three technical replicates.